share_log

Cantor Fitzgerald Reiterates Overweight on Aurinia Pharmaceuticals, Maintains $10 Price Target

Cantor Fitzgerald Reiterates Overweight on Aurinia Pharmaceuticals, Maintains $10 Price Target

康泰纳菲(Cantor Fitzgerald)重申对Aurinia Pharmaceuticals的股票评级为超重,维持10美元的目标价位。
Benzinga ·  09/16 11:22  · 评级/大行评级

Cantor Fitzgerald analyst Olivia Brayer reiterates Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Overweight and maintains $10 price target.

康特菲茨杰分析师Olivia Brayer重申对aurinia pharmaceuticals(纳斯达克:AUPH)为超配,维持目标价格为10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发